| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Naylor Dana Institute for Disease Prevention, American Health Foundation, Valhalla, New York 10595
The environmental carcinogen, 5-methylchrysene, is more carcinogenic than are any of the other monomethylchrysene isomers or chrysene. For investigation of the site of metabolic activation of 5-methylchrysene, a series of fluorinated 5-methylchrysene derivatives was prepared and tested for tumor-initiating activity on mouse skin. The compounds tested were 1-fluoro-5-methylchrysene, 3-fluoro-5-methylchrysene, 6-fluoro-5-methylchrysene, 7-fluoro-5-methylchrysene, 9-fluoro-5-methylchrysene, 11-fluoro-5-methylchrysene, and 12-fluoro-5-methylchrysene, as well as 5,12-dimethylchrysene and 12-methoxy-5-methylchrysene. Each compound was assayed at total initiating doses of 30 or 100 µg with promotion by three-times weekly application of 2.5 µg of tetradecanoylphorbol acetate. Of the fluoro compounds, 12-fluoro-5-methylchrysene, 1-fluoro-5-methylchrysene, and 3-fluoro-5-methylchrysene were less active than was 5-methylchrysene, whereas 6-fluoro-5-methylchrysene, 7-fluoro-5-methylchrysene, 9-fluoro-5-methylchrysene, and 11-fluoro-5-methylchrysene were as potent as was 5-methylchrysene. Both 5,12-dimethylchrysene and 12-methoxy-5-methylchrysene were also less active than was 5-methylchrysene. These results indicate that positions 12, 1, and 3 of 5-methylchrysene are involved in metabolic activation to the ultimate carcinogen. The requirements favoring carcinogenicity in this series are a bay-region methyl group and an unhindered peri position adjacent to an unsubstituted angular ring.
1 Supported by Grant CA-16352 from the National Cancer Institute. Presented in part at the 68th Annual Meeting of the American Association for Cancer Research, Denver, Colo., May 1977 (11). This is paper 8 of the series, "A Study of Chemical Carcinogenesis." The numbering system for the chrysene ring system is shown in Chart 5.
2 Recipient of Research Career Development Award KO4-CA00124 from the National Cancer Institute.
Received 12/ 5/77. Accepted 2/20/78.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Cell Growth & Differentiation |